TVGN · Tevogen Bio Holdings Inc.
$5.04
+0.90 (+21.59%)
At close · Jul 27
Market Cap
$18.80M
Shares
4.19M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ryan Saadi | CEO | $10,421,000 |
| Kirti Desai | CFO | $1,230,000 |
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | $722,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ryan Saadi | CEO | $87,764,783 |
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | $350,000 |
| Kirti Desai | CFO | $300,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Neal Flomenberg | Chief Scientific Officer and Global R&D Lead | $2,926,000 |
| Ryan Saadi | CEO | $501,000 |
| Kirti Desai | CFO | $300,000 |